You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 122 No. 9, September 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  STUDIES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (54)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Chemotherapy-Induced Acral Erythema in Patients Receiving Bone Marrow Transplantation

Michael Kenneth Crider, MD; Jan Jansen, MD; Arthur L. Norins, MD; Michael S. McHale, MD

Arch Dermatol. 1986;122(9):1023-1027.


Abstract



• Chemotherapy-induced acral erythema is an uncommon and distinctive syndrome of intense macular erythema of the palms and fingers seen in patients treated with high-dose chemotherapy. It is painful, may form bullae, and heals uneventfully with desquamation. The incidence (35%) of this complication in patients receiving bone marrow transplantation at our institution is quite high and probably reflects the exceptional doses of chemotherapy and concomitant total body irradiation these patients receive. Biopsy specimens showed vacuolar change, spongiosis, necrotic keratinocytes, and epidermal atypia. These findings probably result from direct toxic effect and mimic those of acute graft-vs-host disease. Awareness of chemotherapy-induced acral erythema is important to avoid its misdiagnosis as a cutaneous sign of acute graft-vs-host disease. This distinction can usually be made on clinical grounds. If necessary, serial skin biopsy specimens are helpful.

(Arch Dermatol 1986;122:1023-1027)



Author Affiliations



From the Department of Dermatology (Drs Crider and Norins), and the Bone Marrow Transplantation Program, Departments of Medicine and Pediatrics (Drs Jansen and McHale), Indiana University Medical Center, Indianapolis.


Footnotes



Accepted for publication April 23, 1986.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor Therapy
Azad et al.
Clin. Cancer Res. 2009;15:1411-1416.
ABSTRACT | FULL TEXT  

Palmar-plantar erythrodysesthesia
Gilbar
J Oncol Pharm Pract 2003;9:137-150.
ABSTRACT  

Chemotherapy-Induced Acral Erythema Showing Vasculitic Histologic Features
Ro et al.
Arch Dermatol 1991;127:1588-1589.
ABSTRACT  

T-Lymphocyte Subsets in the Lesional Skin of Allogeneic and Autologous Bone Marrow Transplant Patients
Paller et al.
Arch Dermatol 1988;124:1795-1801.
ABSTRACT  

Acute Follicular Graft-vs-Host Reaction: A Distinct Clinicopathologic Presentation
Friedman et al.
Arch Dermatol 1988;124:688-691.
ABSTRACT  

Acral Erythema: Graft-vs-Host Disease or Toxicoderma?
Martin-Ortega et al.
Arch Dermatol 1987;123:424-424.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.